African scientists have developed a nanoscale drug delivery system to treat pericarditis, a drug-resistant and lethal ...

Researchers at Martin Luther University Halle-Wittenberg (MLU) have developed a promising new substance for targeting ...

The novel antibiotic candidate sorfequiline has the potential to shorten and improve tuberculosis (TB) treatment when combined with pretomanid and linezolid (SPaL), according to new clinical trial ...

MUMBAI: A Kandivli couple's joy at having twins after IVF treatment was tinged with sadness as their boys were diagnosed with drug-resistant tuberculosis (TB) during Diwali when they were barely a ...

Tuberculosis (TB) is one of the oldest and deadliest infectious diseases we know. It commonly impacts the lungs, but can also affect other areas of the body like the spine, brain or kidneys.

The World Health Organization (WHO) is on a mission to end the tuberculosis (TB) epidemic by 2035. Part of its strategy to achieve this includes reaching a TB treatment success rate of 90 percent by ...

Drug-resistant tuberculosis (DR-TB) heavily contributes to the global challenge of antimicrobial resistance (AMR), resulting ...

The World Health Organization’s Global Tuberculosis Report 2025 was a mixed bag for India. While the tuberculosis (TB) incidence had the highest decline rate, globally, by 21% from 237 per lakh ...

With eight in ten patients entering a hospital carrying drug-resistant bacteria, India now sits at the centre of a silent global crisis, forcing doctors to use last-line medicines, raising risks ...

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...

Drug-resistant superbugs are a growing health threat across Europe, and they could “reverse years of medical progress,” health authorities warned in a new report. Antimicrobial resistance (AMR) occurs ...